Lupagen Inc.

Lupagen Inc.

Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and delivery platform. Lupagen’s systems are deployed using standard apheresis-based platform customized for a diverse range of gene therapies that require targeted genetic or cellular modification of selective populations of a patient’s circulating peripheral blood mononuclear cells.

Company details

8951 Cypress Waters Blvd,Dallas,75019

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Globally (various continents)

Contact supplier

Drop file here or browse